Innovation is the first driving force to lead the development and reform of the new economy, in the face of the complex and difficult market environment in the current epidemic era, only by adhering to the concept of innovative development and transforming the mode of economic growth can we promote the high-quality development of China's economy. Venture capital is undoubtedly an inexhaustible source of power for the transformation and development of China's real enterprises and independent innovation.

In order to pay tribute to the annual benchmark of the venture capital industry, praise the market role model of the venture capital industry, and promote the high-quality development of venture capital, China Venture Capital Research Institute relies on its profound research background and huge market research data for nearly 20 years, and through data analysis, performance evaluation, industry influence and other levels of strict screening, to create an authoritative, comprehensive and objective list in the industry - the annual list of China's venture capital industry and the Golden Investment Award List.

On November 11, the 9 China Venture Capital Industry Annual List and Golden Investment Award List was grandly announced, and five major systems were selected respectively, including the Early Stage, VC, PE, LP and Industry Lists, covering 2021 sub-lists, and comprehensively commending investment institutions and investors who have made major breakthroughs and outstanding contributions in China's venture capital industry and created social benefits.

CVCRI 2021 China Venture Capital Industry Annual List and Golden Investment Award List

List of winners

New Value Capital won the "Top 2021 Best Investment Institutions in China's Healthcare Field" at the 30 China Venture Capital Industry Annual Golden Investment Award

 

 

Early listing

Top 2021 early investment institutions in China in 30

 

Top 2021 early investors in China in 30

 

VC Leaderboard

Top 2021 Chinese Influential VC Investment Institutions in 50

 

Top 2021 Growth VC Investment Institutions in China in 20

 

2021年度中国新锐VC投资机构TOP10

 

Top 2021 Chinese Influential VC Investors in 50

Introduction of New Value:

Shenzhen XinValue Capital Management Co., Ltd. is a private equity fund management company registered and filed by Asset Management Association of China Securities Regulatory Commission (record number: P1003636) focusing on investment in the fields of artificial intelligence, biomedical, advanced manufacturing and TMT. The company's core shareholders manage more than 200 billion yuan of corporate assets, located in the Shenzhen-Hong Kong Modern Service Industry Cooperation Zone - Shenzhen Qianhai, and approved by Shenzhen Qianhai Administration and Shenzhen Market Supervision Administration, is a private equity investment fund management institution with fund management, investment management and investment consulting as its main business.

The company has a management team with a global vision and background that is familiar with the global economy, capital market, financial market, and the latest scientific and technological development trends, in-depth and professional industrial dynamics and industry research, so as to make accurate investment value judgments for investors, so as to create value for investors and society.